Darwin Global Management, Ltd. Fulcrum Therapeutics, Inc. Transaction History

Darwin Global Management, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$9.96 - $23.65 $3.16 Million - $7.51 Million	-317,428 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.0 - $28.44 $3.97 Million - $8.06 Million	283,431 Added 833.69%	317,428 $5.62 Million
Q3 2021 Nov 15, 2021	BUY	$7.28 - $30.97 $247,498 - $1.05 Million	33,997 New	33,997 $959,000
Q2 2021 Aug 16, 2021	SELL	$8.09 - $12.0 $403,432 - $598,416	-49,868 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$10.94 - $15.32 $125,208 - $175,337	-11,445 Reduced 18.67%	49,868 $587,000
Q4 2020 Feb 16, 2021	BUY	$7.84 - $13.4 $480,693 - $821,594	61,313 New	61,313 $718,000

138

59.3M

4.33M

309K

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $167M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

Stay updated on Darwin Global Management, Ltd. with notifications on news.